2025 H1 -tulosraportti
140 päivää sitten38 min
Tarjoustasot
Oslo Børs
Määrä
Osto
1 600
Myynti
Määrä
6 971
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 778 | - | - | ||
| 498 | - | - | ||
| 3 780 | - | - | ||
| 4 149 | - | - | ||
| 11 161 | - | - |
Ylin
4,94VWAP
Alin
4,835VaihtoMäärä
1,3 262 498
VWAP
Ylin
4,94Alin
4,835VaihtoMäärä
1,3 262 498
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 26.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 H1 -tulosraportti | 29.8.2025 | |
| 2025 Q2 -tulosraportti | 29.8.2025 | |
| 2024 H2 -tulosraportti | 26.2.2025 | |
| 2024 Q4 -tulosraportti | 26.2.2025 | |
| 2024 H1 -tulosraportti | 30.8.2024 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·3 t sittenThis is what Investtech says, and we see it every day: "Volume has previously been high around price tops and low around price bottoms. This strengthens the trend picture. The stock is considered overall technically positive in the medium term".
·4 min sittenThe technical analysis of Thor Medical (TRMED.OL) as of January 2026 shows a generally positive momentum characterized by a rising trend channel in the medium term. Trend and Support Levels Rising trend: The stock is moving in a positive trend channel, which indicates increasing optimism among investors. Important support: A technical support level has been established around 4.74 NOK. The stock has recently tested this level, and a break below this point could trigger a sell signal. Resistance: The stock has previously broken through the resistance at 4.74 NOK, which technically signals potential for further increase. Technical Indicators RSI (Relative Strength Index): The RSI curve shows a rising trend, which supports the positive momentum. Short-term measurements have previously shown RSI over 70, which indicates strong buying pressure. Moving average: The 200-day moving average is approximately 4.54 NOK, which gives a "Buy" signal in the long-term perspective. Short-term averages (5 and 50 days) have, however, shown more neutral or negative tendencies around the price of 5.12-5.17 NOK. Volume: There is good correlation between volume and price development (high volume at peaks, low at bottoms), which strengthens the validity of the current trend. Current Price and Trading Price level: The stock is trading in mid-January 2026 around 5.00 - 5.15 NOK. 52-week range: The price has fluctuated between 1.80 and 5.45 NOK over the past year. Conclusion: Thor Medical is currently considered a "buy candidate" based on the trend analysis, as long as the price stays above the support level at 4.74 NOK.
·1 päivä sittenOk. The reason I posted "news" from Nordnett's AI news is that I thought it would be fun to ask the AI what is meant by «remarkable». I actually thought it was a good answer. What is remarkable and a bit funny are the reactions to this 😂
·1 päivä sittenDirect misinformation in Nordnet's news on this page again today. As many have pointed out in various posts below, Must Invest AS has neither sold nor bought shares in TRMED recently. There has only been a change in the top 50 list due to other shareholders. That AI still makes many mistakes and invents some things is relatively well-known, it must be fact-checked. That Nordnet uncritically publishes misinformation that can be price-driving, I find very problematic. I encourage everyone who agrees to take 2 min to send them their opinion on the matter.- ·1 päivä sittentoday at 07:03 ∙ News summary (AI) MUST INVEST AS originally exited Thor Medical's shareholder list, indicating a complete sale or a reduction below the reporting threshold. Subsequently, the investor re-established a position in the company by buying 700,000 shares. This re-entry represents a 0.2% stake in Thor Medical, marking a remarkable change in the company's investor base. MUST INVEST AS exited Thor Medical's shareholder list. MUST INVEST AS subsequently bought 700,000 shares in Thor Medical. The new holding from MUST INVEST AS represents a 0.2% stake in Thor Medical.·1 päivä sittenThis is just as wrong today as when it was discussed whether he had sold a few days ago.
1 päivä sitten1 päivä sittenhttps://www.alphatau.com/single-post/alpha-tau-submits-first-pre-market-approval-module-to-the-fda-for-alpha-dart-for-the-treatment-of-r The FDA process is officially underway. This is a significant step towards the potential approval of Alpha DaRT in the United States. The Ra-224 market is small and there are few suppliers. Currently, there are only a few industrial producers of Ra-224. Alpha Tau needs a reliable, scalable supplier…
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 H1 -tulosraportti
140 päivää sitten38 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·3 t sittenThis is what Investtech says, and we see it every day: "Volume has previously been high around price tops and low around price bottoms. This strengthens the trend picture. The stock is considered overall technically positive in the medium term".·4 min sittenThe technical analysis of Thor Medical (TRMED.OL) as of January 2026 shows a generally positive momentum characterized by a rising trend channel in the medium term. Trend and Support Levels Rising trend: The stock is moving in a positive trend channel, which indicates increasing optimism among investors. Important support: A technical support level has been established around 4.74 NOK. The stock has recently tested this level, and a break below this point could trigger a sell signal. Resistance: The stock has previously broken through the resistance at 4.74 NOK, which technically signals potential for further increase. Technical Indicators RSI (Relative Strength Index): The RSI curve shows a rising trend, which supports the positive momentum. Short-term measurements have previously shown RSI over 70, which indicates strong buying pressure. Moving average: The 200-day moving average is approximately 4.54 NOK, which gives a "Buy" signal in the long-term perspective. Short-term averages (5 and 50 days) have, however, shown more neutral or negative tendencies around the price of 5.12-5.17 NOK. Volume: There is good correlation between volume and price development (high volume at peaks, low at bottoms), which strengthens the validity of the current trend. Current Price and Trading Price level: The stock is trading in mid-January 2026 around 5.00 - 5.15 NOK. 52-week range: The price has fluctuated between 1.80 and 5.45 NOK over the past year. Conclusion: Thor Medical is currently considered a "buy candidate" based on the trend analysis, as long as the price stays above the support level at 4.74 NOK.
- ·1 päivä sittenOk. The reason I posted "news" from Nordnett's AI news is that I thought it would be fun to ask the AI what is meant by «remarkable». I actually thought it was a good answer. What is remarkable and a bit funny are the reactions to this 😂
- ·1 päivä sittenDirect misinformation in Nordnet's news on this page again today. As many have pointed out in various posts below, Must Invest AS has neither sold nor bought shares in TRMED recently. There has only been a change in the top 50 list due to other shareholders. That AI still makes many mistakes and invents some things is relatively well-known, it must be fact-checked. That Nordnet uncritically publishes misinformation that can be price-driving, I find very problematic. I encourage everyone who agrees to take 2 min to send them their opinion on the matter.
- ·1 päivä sittentoday at 07:03 ∙ News summary (AI) MUST INVEST AS originally exited Thor Medical's shareholder list, indicating a complete sale or a reduction below the reporting threshold. Subsequently, the investor re-established a position in the company by buying 700,000 shares. This re-entry represents a 0.2% stake in Thor Medical, marking a remarkable change in the company's investor base. MUST INVEST AS exited Thor Medical's shareholder list. MUST INVEST AS subsequently bought 700,000 shares in Thor Medical. The new holding from MUST INVEST AS represents a 0.2% stake in Thor Medical.·1 päivä sittenThis is just as wrong today as when it was discussed whether he had sold a few days ago.
- 1 päivä sitten1 päivä sittenhttps://www.alphatau.com/single-post/alpha-tau-submits-first-pre-market-approval-module-to-the-fda-for-alpha-dart-for-the-treatment-of-r The FDA process is officially underway. This is a significant step towards the potential approval of Alpha DaRT in the United States. The Ra-224 market is small and there are few suppliers. Currently, there are only a few industrial producers of Ra-224. Alpha Tau needs a reliable, scalable supplier…
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
1 600
Myynti
Määrä
6 971
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 778 | - | - | ||
| 498 | - | - | ||
| 3 780 | - | - | ||
| 4 149 | - | - | ||
| 11 161 | - | - |
Ylin
4,94VWAP
Alin
4,835VaihtoMäärä
1,3 262 498
VWAP
Ylin
4,94Alin
4,835VaihtoMäärä
1,3 262 498
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 26.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 H1 -tulosraportti | 29.8.2025 | |
| 2025 Q2 -tulosraportti | 29.8.2025 | |
| 2024 H2 -tulosraportti | 26.2.2025 | |
| 2024 Q4 -tulosraportti | 26.2.2025 | |
| 2024 H1 -tulosraportti | 30.8.2024 |
2025 H1 -tulosraportti
140 päivää sitten38 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 26.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 H1 -tulosraportti | 29.8.2025 | |
| 2025 Q2 -tulosraportti | 29.8.2025 | |
| 2024 H2 -tulosraportti | 26.2.2025 | |
| 2024 Q4 -tulosraportti | 26.2.2025 | |
| 2024 H1 -tulosraportti | 30.8.2024 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·3 t sittenThis is what Investtech says, and we see it every day: "Volume has previously been high around price tops and low around price bottoms. This strengthens the trend picture. The stock is considered overall technically positive in the medium term".·4 min sittenThe technical analysis of Thor Medical (TRMED.OL) as of January 2026 shows a generally positive momentum characterized by a rising trend channel in the medium term. Trend and Support Levels Rising trend: The stock is moving in a positive trend channel, which indicates increasing optimism among investors. Important support: A technical support level has been established around 4.74 NOK. The stock has recently tested this level, and a break below this point could trigger a sell signal. Resistance: The stock has previously broken through the resistance at 4.74 NOK, which technically signals potential for further increase. Technical Indicators RSI (Relative Strength Index): The RSI curve shows a rising trend, which supports the positive momentum. Short-term measurements have previously shown RSI over 70, which indicates strong buying pressure. Moving average: The 200-day moving average is approximately 4.54 NOK, which gives a "Buy" signal in the long-term perspective. Short-term averages (5 and 50 days) have, however, shown more neutral or negative tendencies around the price of 5.12-5.17 NOK. Volume: There is good correlation between volume and price development (high volume at peaks, low at bottoms), which strengthens the validity of the current trend. Current Price and Trading Price level: The stock is trading in mid-January 2026 around 5.00 - 5.15 NOK. 52-week range: The price has fluctuated between 1.80 and 5.45 NOK over the past year. Conclusion: Thor Medical is currently considered a "buy candidate" based on the trend analysis, as long as the price stays above the support level at 4.74 NOK.
- ·1 päivä sittenOk. The reason I posted "news" from Nordnett's AI news is that I thought it would be fun to ask the AI what is meant by «remarkable». I actually thought it was a good answer. What is remarkable and a bit funny are the reactions to this 😂
- ·1 päivä sittenDirect misinformation in Nordnet's news on this page again today. As many have pointed out in various posts below, Must Invest AS has neither sold nor bought shares in TRMED recently. There has only been a change in the top 50 list due to other shareholders. That AI still makes many mistakes and invents some things is relatively well-known, it must be fact-checked. That Nordnet uncritically publishes misinformation that can be price-driving, I find very problematic. I encourage everyone who agrees to take 2 min to send them their opinion on the matter.
- ·1 päivä sittentoday at 07:03 ∙ News summary (AI) MUST INVEST AS originally exited Thor Medical's shareholder list, indicating a complete sale or a reduction below the reporting threshold. Subsequently, the investor re-established a position in the company by buying 700,000 shares. This re-entry represents a 0.2% stake in Thor Medical, marking a remarkable change in the company's investor base. MUST INVEST AS exited Thor Medical's shareholder list. MUST INVEST AS subsequently bought 700,000 shares in Thor Medical. The new holding from MUST INVEST AS represents a 0.2% stake in Thor Medical.·1 päivä sittenThis is just as wrong today as when it was discussed whether he had sold a few days ago.
- 1 päivä sitten1 päivä sittenhttps://www.alphatau.com/single-post/alpha-tau-submits-first-pre-market-approval-module-to-the-fda-for-alpha-dart-for-the-treatment-of-r The FDA process is officially underway. This is a significant step towards the potential approval of Alpha DaRT in the United States. The Ra-224 market is small and there are few suppliers. Currently, there are only a few industrial producers of Ra-224. Alpha Tau needs a reliable, scalable supplier…
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
1 600
Myynti
Määrä
6 971
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 778 | - | - | ||
| 498 | - | - | ||
| 3 780 | - | - | ||
| 4 149 | - | - | ||
| 11 161 | - | - |
Ylin
4,94VWAP
Alin
4,835VaihtoMäärä
1,3 262 498
VWAP
Ylin
4,94Alin
4,835VaihtoMäärä
1,3 262 498
Välittäjätilasto
Dataa ei löytynyt